Table: Modalis Therapeutics -Q1 group results

Modalis Therapeutics

09/05/2022 07:00

May 9 (Reuters)- 
             Modalis Therapeutics Corporation 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   3 months ended      3 months ended       Year to 
                  Mar 31, 2022        Mar 31, 2021     Dec 31, 2022 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales              40 mln               0 mln                     
                                       (-95.4 pct)                  
  Operating       loss 466 mln        loss 252 mln                  
  Recurring       loss 443 mln        loss 245 mln                  
  Net             loss 438 mln           201 mln                    
  EPS            loss 15.13 yen         7.07 yen                    
  EPS Diluted                           6.66 yen                    
  Ann Div                                  NIL              NIL     
  -Q2 div                                  NIL              NIL     
  -Q4 div                                  NIL              NIL     
  
  NOTE - Modalis Therapeutics Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4883.T